卡尔帕因2调节IL-1α分泌,并通过调节瘤微环境中的卡尔帕因1表达来抑制瘤的发展

相关实验视频

Updated: Jun 2, 2025

08:41

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages

Published on: April 6, 2022

2.6K

Zuhairah Binte Hanafi^1,2, Yu Mei^1,2, Huey Yee Teo^1,2

¹Immunology Programme, Life Sciences Institute; Centre for Life Sciences, National University of Singapore, Singapore, Singapore.

Oncoimmunology

|January 13, 2025

概括

卡尔帕因2调节介素-1α (IL-1α) 的分泌,影响肝细胞癌. 它的缺陷通过增加IL-1α通过FoxO3和calpain1增强癌症,揭示了新的治疗点.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

促进瘤的炎症对于癌症的进展至关重要.
针对炎症性细胞因子显示出治疗的前景.
介素-1α (IL-1α) 是炎症和致癌的关键.
人们对瘤微环境中的IL-1α分泌物了解甚少.
卡尔帕因1切割亲IL-1α,促进肝细胞癌 (HCC).

研究的目的:

研究calpain 2在IL-1α分泌和HCC进展中的作用.
阐明calpain 2影响IL-1α分泌的机制.
根据calpain-IL-1α相互作用来确定HCC的潜在治疗点.

主要方法:

使用小鼠模型研究了calpain 2在IL-1α分泌中的作用.
分析了calpain 2缺乏HCC的基因表达变化.
研究了calpain 2,calpain 1,FoxO3和IL-1α之间的关系.

主要成果:

卡尔二缺乏症在富含IL-1α的环境中增强了HCC的发展.
卡尔帕因2缺乏导致卡尔帕因1表达增加,这表明补偿.
卡尔巴因2缺乏增加了FoxO3的表达,这可以调节卡尔巴因1.
这种机制增加了IL-1α的分泌,促进了HCC.

结论:

卡尔帕因2通过FoxO3介导的卡尔帕因1调节IL-1α分泌.
这一途径代表了肝细胞癌的新疗法策略.
了解calpain家族相互作用为癌症治疗提供了新的目标.

关键词:

卡尔帕因 2 疼痛感 2 疼痛感它们的IL-1α.在MDSCs中.肝细胞癌是肝细胞癌.瘤微环境是一个微环境.

相关概念视频

01:24

Caspases

12.3K

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...

12.3K

01:16

Calmodulin-dependent Signaling

5.1K

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

5.1K

02:26

NF-κB-dependent Signaling Pathway

7.2K

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

7.2K

02:17

The Tumor Microenvironment

6.5K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

6.5K

03:03

mTOR Signaling and Cancer Progression

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...